Eli Lilly’s senior VP for discovery and clinical research, William Chin, is heading to Harvard Medical School, reports the Wall Street Journal Health Blog. There, Chin will be the executive dean for research, a new position. According to the medical school dean, Chin will "conceptualize and develop new research initiatives, such as the therapeutics discovery initiative, envisioned as a focused and innovative effort to bring together the enormous expertise of our community in order to find effective new ways for transforming the world’s most vital biomedical research into therapies that can directly improve human health." Prior to joining Lilly, Chin was a professor at Harvard, where he also received his medical degree.
Back to the Ivy
Feb 12, 2010